The FTC asked that 'pharma bro' Martin Shkreli be held in contempt for failing to comply with an investigation into whether he violated his ban from the pharmaceuticals industry
The Federal Trade Commission on Friday asked that “pharma bro” Martin Shkreli be held in contempt for failing to comply with an investigation into whether he violated a court order banning him from the pharmaceutical industry.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
‘Pharma bro’ Martin Shkreli yet to pay $65M fine for lifetime ban: FTCThe FTC said the “pharma bro” pay hasn’t paid any of a $64.6 million penalty that accompanied the ban.
続きを読む »
FTC Alleges Martin 'Pharma Bro' Shkreli Is Trying to Break Back Into Pharma IndustryA federal judge previously barred the former CEO of Vyera Pharmaceutical from in any way working with or in the pharma industry again.
続きを読む »
FTC calls on federal court to hold 'pharma bro' Martin Shkreli in contempt | CNN BusinessThe Federal Trade Commission on Friday called for a federal court to hold 'Pharma Bro' Martin Shkreli in contempt after Shkreli allegedly flouted a recent FTC investigation into his business dealings and failed to make a $64.6 million payment he owed for his prior wrongdoings.
続きを読む »
Feds Wants ‘Pharma Bro’ Martin Shkreli Held in ContemptAuthorities say Shkreli hasn’t paid a $64.6 million judgment and may be violating a court order barring him from the pharmaceutical business.
続きを読む »
FTC calls for Martin Shkreli to be held in contempt of court for forming new drug companyThe FTC on Friday asked that Martin Shkreli be held in contempt of court for forming a new drug company in violation of a judge’s ban on the convicted fraudster from working in the pharmaceuticals industry.
続きを読む »
FTC Asks Judge to Hold ‘Pharma Bro' Martin Shkreli in Contempt of Court for Forming New Drug FirmThe FTC asked that notorious 'pharma bro' Martin Shkreli be held in contempt of court for forming a new drug company in violation of a judge's ban on the convicted fraudster from working in the pharmaceuticals industry.
続きを読む »